BioCryst Pharmaceuticals
BCRX
#5073
Rank
C$2.23 B
Marketcap
C$10.60
Share price
-3.07%
Change (1 day)
-3.62%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$1.16 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are C$1.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$1.38 B7.51%
2023-12-31C$1.28 B12.55%
2022-12-31C$1.14 B29.37%
2021-12-31C$0.88 B96.28%
2020-12-31C$0.45 B152.19%
2019-12-31C$0.17 B34.61%
2018-12-31C$0.13 B11.92%
2017-12-31C$0.11 B0.15%
2016-12-31C$0.11 B14.57%
2015-12-31C$0.10 B45.69%
2014-12-31C$71.06 M33.54%
2013-12-31C$53.21 M-7.56%
2012-12-31C$57.56 M-16.03%
2011-12-31C$68.56 M56.08%
2010-12-31C$43.92 M-25.35%
2009-12-31C$58.84 M26.47%
2008-12-31C$46.52 M-40.06%
2007-12-31C$77.62 M40.86%
2006-12-31C$55.1 M15.99%
2005-12-31C$47.51 M1162.01%
2004-12-31C$3.76 M76.06%
2003-12-31C$2.13 M15.52%
2002-12-31C$1.85 M-49.1%
2001-12-31C$3.63 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Repligen
RGEN
C$1.17 B 0.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$3.03 B 160.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$1.82 M-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.86 B 60.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$51.75 B 4,344.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$69.9 M-94.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$85.55 B 7,245.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
C$1.22 B 5.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$18.58 M-98.40%๐Ÿ‡บ๐Ÿ‡ธ USA